There results could not have been much better for cohort 1, 6 of 7 participants reported reduced proteins…
From the * report,
It is not yet known why one subject in Cohort 1 did not have decreased blood p-RPS6KB1 and p-EIF4EBP1 protein levels, however initial analysis indicates it may be associated with an individual’s metabolic activity and/or tablet administration compliance issues.
“These possibilities will be explored with the ongoing analysis of the Cohort 2 data so that we can better interpret these results,” the company said.
There results could not have been much better for cohort 1, 6 of...
-
- There are more pages in this discussion • 327 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |